NCT02363894View on ClinicalTrials.gov

DEFINITIVE AR Two Year Follow-up Extension Study

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Peripheral Arterial Disease
Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT02363894 - DEFINITIVE AR Two Year Follow-up Extension Study | Biotech Hunter | Biotech Hunter